| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Revenue | $535.8M | +11.8% |
| Cost of Revenue | $377.7M | +16.3% |
| Gross Profit | $158.1M | +2.3% |
| R&D Expense | $7.3M | -3.8% |
| SG&A Expense | $65.5M | +6.3% |
| Operating Income | $44.8M | -7.5% |
| Pre-tax Income | $49.4M | +2.4% |
| Income Tax | $9.8M | -13.8% |
| Net Income | $39.6M |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.8M | +13.6% |
| Accounts Receivable | $59.1M | +7.1% |
| Current Assets | $287.9M | -1.4% |
| Total Assets | $578.0M | +6.8% |
| Current Liabilities | $96.7M | +10.9% |
| Total Liabilities | $179.8M | +14.8% |
| Stockholders' Equity | $398.2M | +3.5% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $106.7M | +537.9% |
| Capital Expenditures | $90.8M | +1.3% |
| Investing Cash Flow | -$81.5M | +9.2% |
| Financing Cash Flow | -$18.0M | -405.7% |
| Free Cash Flow | $16.0M | +121.9% |
| +7.4% |
| EPS (Basic) | $0.86 | +7.5% |
| EPS (Diluted) | $0.86 | +7.5% |